Immediate Impact

80 standout
Sub-graph 1 of 21

Citing Papers

Postmenopausal Osteoporosis
2023 Standout
Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial
2022 Standout
5 intermediate papers

Works of K. Vandormael being referenced

Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study
2009
Lipid-altering efficacy of switching from atorvastatin 10 mg/day to ezetimibe/simvastatin 10/20 mg/day compared to doubling the dose of atorvastatin in hypercholesterolaemic patients with atherosclerosis or coronary heart disease
2005
and 1 more

Author Peers

Author Last Decade Papers Cites
K. Vandormael 271 78 362 475 13 805
Mohamed A. Omar 449 131 167 160 29 931
Wentao Wu 118 12 270 408 16 856
Sheryl L. Silfen 217 13 309 153 25 969
Zhousheng Xiao 115 11 261 78 12 964
Jennifer Baker 464 84 74 106 7 753
G Crepaldi 130 5 443 345 24 930
Louise Stuart 122 45 145 266 13 698
Minh Duong-Hua 88 47 235 45 11 852
Henry Schmitt 86 7 290 154 12 776
Matthew Davies 138 10 81 74 28 918

All Works

Loading papers...

Rankless by CCL
2026